The FDA backs off a hasty — and damaging — emergency OK for a potentially dangerous Covid-19 drug
The FDA rushed in with an emergency authorization less than 3 months ago to allow anxious, frightened people the opportunity of using two malaria drugs to ward off Covid-19. One of them, hydroxychloroquine, arrived with the repeated endorsement of President Donald Trump — who ended up taking it himself — and various Fox News commentators. But with the evidence of its uselessness for guarding against coronavirus growing, as data on potential safety risks mounted amid a chorus of expert warnings, the agency reversed itself on Monday and revoked the green light.
This article is for premium subscribers only
Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.